Dr. Hendrik Luesch and a team of researchers have discovered a novel marine natural product that binds to a new site of tubulin, an important target for cancer drugs.
Researchers in the UF College of Pharmacy teamed with collaborators in Singapore to study a novel drug candidate with marine origins as a new method to prevent or treat vision loss.
A UF College of Pharmacy researcher team led by Dr. Hendrik Luesch recently developed a novel molecule based on marine cyanobacteria, Apra S10, to target pancreatic cancer cells.
Natural Product Reports is the Royal Society of Chemistry’s journal for publication of reviews in all areas of natural products chemistry, including biosynthesis, chemical biology, pharmacology and organic synthesis.
Luesch's marine drug discovery research is highlighted in the video supporting UF's $3 billion fundraising campaign.
The symposium featured nearly 130 participants and plenary speakers from the Dana-Farber Cancer Institute, Scripps Research Institute-Florida and National Cancer Institute.
Hendrik Luesch, Ph.D., a professor and chair of medicinal chemistry and the Debbie and Sylvia DeSantis Chair in Natural Products Drug Discovery and Development, received the Golden Medal Award for his presentation at the 2nd International Conference on Herbal and Traditional Medicine.
University of Florida pharmacy researchers have identified novel drug targets and a new screening method for drugs affecting the signaling pathways in colorectal cancer.
Hendrik Luesch, Ph.D., the Debbie and Sylvia DeSantis Chair in Natural Products Drug Discovery and Development in the UF College of Pharmacy, was one of two faculty named as the UF Foundation 2014 Preeminence Term Professors. Now in its second year, the University of Florida…